Medadvisor Ltd (ASX:MDR) FY23 results show progress, but problems remain
There are some tantalising aspects to the MedAdvisor (ASX: MDR) thesis, but is it a bit too risky?
MedAdvisor (ASX: MDR)
MedAdvisor Limited (ASX: MDR) is an Australian digital health company founded in 2010 and headquartered in Melbourne. It specialises in pharmacy-driven patient engagement solutions aimed at improving medication adherence. The company’s platform, THRiV, is a cloud-based, AI-enabled system that facilitates personalised patient experiences and enhances pharmacy workflows.
MedAdvisor operates across Australia, New Zealand, the United States, the United Kingdom, and Asia, serving over 34,000 pharmacies and connecting with more than 3.7 million patients in Australia alone. The company was readmitted to the ASX on 1 December 2015 following a reverse takeover by Exalt Resources Limited.
MedAdvisor continues to expand its global footprint, focusing on digital solutions that support better health outcomes.
MedAdvisor (ASX: MDR) Goes Cashflow Positive In Record Result
The Q2 FY 2023 MedAdvisor quarterly cash flow report showed record receipts and more than $21 million operating cashflow, in a quarter, from a company with a market cap of less than $165 million.
Is MedAdvisor (ASX: MDR) At A Transition Point?
With a new CEO, the acquisition of Guildlink, and the forecast that it will be “breakeven at an earnings level in FY23,” MedAdvisor is pointing to brighter days ahead.
But what are the risks?
A Short Case For MedAdvisor (ASX: MDR)
Sorry, you’re not authorised to access this page Hi there, you’re seeing this page because you don’t have a membership OR your account has expired. But I have an account! If you have just logged in to your account and you’re seeing this message, please follow the steps below: 1. Press the … Continued
10 ASX Stocks Benefitting From Social Distancing
A safer place to play? Each of these 10 companies have announced that they are definitely benefitting from the imposition of social distancing…
Medadvisor Ltd (ASX: MDR) Share Price Creeps Higher On Deliveries Launch
The Medadvisor (ASX: MDR) share price is gaining on news it has launched its delivery offering, but long term success is not guaranteed.
MedAdvisor Ltd (ASX: MDR) launches pharmacy-to-home deliveries amidst ongoing share price volatility
While this article focuses on the share market during the pandemic, it in no way seeks to minimise the very real human tragedy that is occurring. MedAdvisor Ltd (ASX: MDR) fell 9.8 per cent on Friday, and also disclosed that Regal Funds Management has been a net seller. The fundie has sold over $1.8m in … Continued